...
首页> 外文期刊>Journal of proteome research >Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model
【24h】

Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model

机译:B16-F10小鼠黑色素瘤模型中肿瘤建立和生长的蛋白质组学分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The B16-F10 mouse model of melanoma is a widely used model to study many aspects of cancer biology and therapeutics in a solid tumor. Melanomas aggressively progress within a dynamic microenvironment containing in addition to tumor cells, stroma cells and components such as fibroblasts, immune cells, vascular cells, extracellular matrix (ECM) and extracellular molecules. The goal of this study was to elucidate the processes of tumor progression by identifying differentially expressed proteins in the tumor mass during specific stages of tumor growth. A comparative proteome analysis was performed on B16-F10 derived tumors in C57BL/6 mice at days 3, 5, 7, and 10. Statistical approaches were used to determine quantitative differential protein expression at each tumor time stage. Hierarchical clustering of 44 protein spots (p < 0.01) revealed a progressive change in the tumor mass when all 4 time stages were classified together, but there was a clear switch in expression of these proteins between the day 5 and the day 7 tumors. A trend analysis showed 53 protein spots (p < 0.001) following 6 predominant kinetic paths of expression as the tumor progressed. The protein spots were then identified using MALDI-TOF mass spectrometry. Proteins involved in glycolysis, inflammation, wounding, superoxide metabolism, and chemotaxis increased during tumorigenesis. From day 3 to day 7 VEGF and active cathepsin D were induced 7-fold and 4-fold, respectively. Proteins involved in electron transport, protein folding, blood coagulation, and transport decreased during tumorigenesis. This work illustrates changes in the biology of the B16-F10 tumor mass during tumor progression.
机译:黑色素瘤的B16-F10小鼠模型是一种广泛使用的模型,用于研究实体瘤中癌症生物学和治疗方法的许多方面。黑色素瘤在动态微环境中积极地发展,除了肿瘤细胞,基质细胞和诸如成纤维细胞,免疫细胞,血管细胞,细胞外基质(ECM)和细胞外分子等成分。这项研究的目的是通过在肿瘤生长的特定阶段鉴定肿瘤块中差异表达的蛋白质来阐明肿瘤进展的过程。在第3、5、7和10天时,对C57BL / 6小鼠中B16-F10衍生的肿瘤进行了比较蛋白质组分析。使用统计方法确定每个肿瘤时间阶段的定量差异蛋白表达。当将所有4个时间阶段归为一类时,44个蛋白点的层次聚类(p <0.01)显示了肿瘤块的进行性变化,但是在第5天和第7天肿瘤之间这些蛋白的表达发生了明显变化。趋势分析显示,随着肿瘤的进展,遵循6条主要的表达动力学路径,共有53个蛋白点(p <0.001)。然后使用MALDI-TOF质谱法鉴定蛋白质斑点。在肿瘤发生期间,参与糖酵解,炎症,伤口,超氧化物代谢和趋化性的蛋白质增加。从第3天到第7天,分别诱导VEGF和活性组织蛋白酶D 7倍和4倍。在肿瘤发生过程中,参与电子转运,蛋白质折叠,血液凝固和转运的蛋白质减少。这项工作说明了肿瘤进展过程中B16-F10肿瘤块的生物学变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号